LINDSAY MCBURNEY: Open Payments
NPI 1336449990 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 26 payments from 13 companies in 2025. Trend: 2023 $556 · 2024 $633 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $97 |
| AERIN MEDICAL INC. | 2 | $70 |
| Novo Nordisk Inc | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| ABBVIE INC. | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Astellas Pharma US Inc | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: INSPIRE, VIVAER STYLUS, TRELEGY ELLIPTA, FARXIGA, Ozempic, Wegovy, Veozah, UBRELVY.
Industry payments across MD — which companies pay providers there.
